So Sir Pascal may seem an unlikely ally of Donald Trump, who as America’s president has slashed public spending on scientific ...

Pascal Soriot, who runs drugs giant AstraZeneca, has slipped to third place in our annual survey, after being replaced by the ...

Melrose CEO Peter Dilnot has overtaken AstraZeneca’s Pascal Soriot as the UK’s highest-paid FTSE 100 boss after a £45m payout ...

Musk isn’t the only billion-dollar CEO. In the past year, the Palantir boss Alex Karp realised $6.8bn from a 2020 equity ...

Richard Alvin on witnessing the devastation of the Altadena fires and why climate denial — from Trump to Clarkson — is a ...

The global trading system is adjusting to the tariffs levied by the United States: for most goods they look likely to settle ...

Europe's pharmaceutical companies are bracing for United States President Donald Trump's plan to slap tariffs of up to 250 ...

Meanwhile, drugmakers ramp up U.S. manufacturing investments to navigate policy shifts and protect supply chain resilience.